Arcturus Therapeutics Holdings (ARCT)
(Delayed Data from NSDQ)
$19.62 USD
+1.57 (8.70%)
Updated Sep 18, 2025 04:00 PM ET
After-Market: $19.72 +0.10 (0.51%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Arcturus Therapeutics Holdings Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ARCT 19.62 +1.57(8.70%)
Will ARCT be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ARCT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ARCT
Should You Buy Arcturus Therapeutics (ARCT) After Golden Cross?
Arcturus Therapeutics (ARCT) Reports Q2 Loss, Tops Revenue Estimates
ARCT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Clearside Biomedical, Inc. (CLSD) Reports Q2 Loss, Beats Revenue Estimates
Insmed (INSM) Reports Q2 Loss, Beats Revenue Estimates
Tango Therapeutics, Inc. (TNGX) Reports Q2 Loss, Lags Revenue Estimates
Other News for ARCT
Cathie Wood's Ark Bets Big On Solana Treasury Play: Makes $162M Investment In Brera Holdings As Stock Explodes 225%
Cathie Wood's Ark Bets Big On Solana Treasury Play: Makes $162M Investment In Brera Holdings As Stock Explodes 225%
ARCT forms Bollinger Band Squeeze on September 18
Cathie Wood Invests $37M into Biotech Stocks, Trims Stake in KTOS, TEM, and ROKU Stocks
Shooting Star Candlestick appears for ARCT after 0.22% move